Drug Therapy
News
EULAR keeps csDMARDs as top PsA drugs
EULAR’s revised psoriatic arthritis recommendations retain methotrexate and other csDMARDS as first-line treatment over TNF inhibitors.
Conference Coverage
To help patients stay on diabetes regimens: Communicate, educate, and use technology
SAN FRANCISCO – Physicians offer insight and advice on helping patients with diabetes take their medications as directed.
Article
Nothing to sneeze at: Upper respiratory infections and mood disorders
URIs can destabilize mood disorders, and OTC cold/flu meds may increase risk of interactions.
Article
Polypharmacy: When might it make sense?
What are factors that could help determine whether a multi-medication regimen might be warranted for your patient?
Conference Coverage
What’s new in pediatric sepsis
LJUBLJANA, SLOVENIA – Don’t obsess about “Golden Hour” for delivering sepsis treatment bundle, expert advises.
News
Anticholinergic drugs linked to dementia in older populations
“Associations were stronger in [dementia] cases diagnosed before the age of 80 years,” the researchers noted.
Conference Coverage
EULAR revises its RA management recommendations
MADRID – Despite some changes, methotrexate remains the first-line drug, and imaging treatment targets remain sidelined.
FDA/CDC
FDA approves pembrolizumab for advanced SCLC
The approval was based on an overall response rate of 19% in two nonrandomized trials.
Conference Coverage
Rapid assay distinguishes viral from bacterial infection
LJUBLJANA, SLOVENIA – Aim is to cut inappropriate antimicrobial therapy in febrile children while awaiting culture...
Latest News
Deaths from drugs, alcohol, and suicide increase among millennials
‘Deaths of despair’ in the United States increased to an all-time high in 2017, and the increase was especially pronounced among young adults,...